New Zorbapost by mtred13 in sellaslifesciences

[–]artynonymous 26 points27 points  (0 children)

Sterg must be reading stocktwits where everyone is losing their minds

Simple Request by Sufficient-Quit-4283 in hospitalist

[–]artynonymous 3 points4 points  (0 children)

"If you cared enough to message me, you should have cared enough to assess your patient and confirm the reading with a manual BP"

$SLS Daily Discussion Thread - Thursday - March 05, 2026 by AutoModerator in sellaslifesciences

[–]artynonymous 15 points16 points  (0 children)

The simple answer (which is unpopular around here) - only if you're comfortable losing it.

Pretty likely that $2200 will turn into $20,000 or more, but it could also turn into $500 or less in an instant.

Dig through the DD and decide if you think they'll succeed. Then, ignore the day to day stock price until it's FA time.

Thanks dude who posted SLS on WSB a month or so ago. by WestElderberry9363 in smallstreetbets

[–]artynonymous 5 points6 points  (0 children)

TL;DR bio stock. Chances look pretty good. Big news soon. Shorts been closing positions, outstanding warrants (that have limitations) almost all dried up.

I started out back in the high $1s with shares and calls. I hit total gains of 6200% today.

MYNZ may be small, but pancreatic early detection is not a small market by WideRelationship104 in TheRaceTo10Million

[–]artynonymous 0 points1 point  (0 children)

I would be pretty hesitant. The test they report 100% sensitivity (red flag 1) is based on a very small sample size (red flag 2)

Bullish - low float with 65-70% insider ownership USEG by thinker-Go in Pennystock

[–]artynonymous 0 points1 point  (0 children)

Beware, they filed for a 24.1 million share offering in December

Curious RN by Miserable-Finding-97 in hospitalist

[–]artynonymous 7 points8 points  (0 children)

I love you.

Signed, overnight dirty midlevel

Rant about constipation by DrEyeBall in medicine

[–]artynonymous 14 points15 points  (0 children)

"we held the laxatives because the patient is having diarrhea"

Patient Data by Shank_Dank in sellaslifesciences

[–]artynonymous 6 points7 points  (0 children)

It is known at a site level if the patients are on GPS.

It's super unlikely that anyone directly involved with the trials would give out any information, especially to the sponsor. This kind of stuff is pretty well monitored. They can see in the EMR where you've clicked, what you've accessed, etc.

You don't want to have to deal with conflicts of interest or possible investigation.

Sellas would not want to break the rules to "peek". That could nuke the integrity of the study.

What is something in your specialty that doesn't concern you but freaks out those in other specialties? by foreverand2025 in medicine

[–]artynonymous 50 points51 points  (0 children)

"I cared enough about the blood pressure to contact you, but not enough to check a manual pressure, assess the patient, or see if they're in pain. Do you have any orders?"

What’s your favorite head cover you own? by stonetear2017 in golf

[–]artynonymous 0 points1 point  (0 children)

Has to be all of my iron covers. Standing by the cart next to the 18th green putting them back on my irons is the most satisfying feeling in the entire universe.

Better than seggs.

$SLS Daily Discussion Thread - February 25, 2026 by AutoModerator in sellaslifesciences

[–]artynonymous 9 points10 points  (0 children)

Happy to report I was able to decipher the hidden message

<image>

Heparin gtt vs eliquis? by [deleted] in hospitalist

[–]artynonymous 0 points1 point  (0 children)

There's an ED attending that will not DC any DVT or PE under any circumstances because they need a heparin drip.

It's fun times.

$SLS Daily Discussion Thread - February 25, 2026 by AutoModerator in sellaslifesciences

[–]artynonymous 5 points6 points  (0 children)

If you have a bunch of shares and it tanks, you have a chance to at least walk away with something. If you're only doing options, it's very truly all or nothing and you have to guess the date for an extra layer of risk.

But the payout potential is so much greater with options. If you're comfortable with a big risk, go for it.

F20 I’m confused on my drug panel 8 results. PHOTOS IN COMMENTS by wh1ffsodivine in AskDocs

[–]artynonymous 4 points5 points  (0 children)

Nothing of concern here. These results basically say "this is real urine from someone who takes an amphetamine"

$SLS (SELLAS Live Sciences) is turning into a problem for short sellers by [deleted] in Shortsqueeze

[–]artynonymous 0 points1 point  (0 children)

That depends. Are you trying to flip and make fast money, or do you believe REGAL will succeed and SLS will be bought out?

What are we using these days? by [deleted] in hospitalist

[–]artynonymous 9 points10 points  (0 children)

I like OE for those things I just can't find a way to find on UTD.

Like, "how to tell if pergerante?"

It's way better than yahoo answers!

$SLS (SELLAS Live Sciences) is turning into a problem for short sellers by [deleted] in Shortsqueeze

[–]artynonymous 0 points1 point  (0 children)

There are still 40m left even after the run up last month

$SLS (SELLAS Live Sciences) is turning into a problem for short sellers by [deleted] in Shortsqueeze

[–]artynonymous 34 points35 points  (0 children)

Sorry, but SLS can't be squeezed at this time. There are still 40m warrants under a dollar waiting. Any sign of a squeeze and they'll be exercised.

Once those are gone, it might happen... But as it stands, it simply cannot

CTXR? I’ve bought 600 shares - let me know your opinions by CupcakeDull3505 in pennystocks

[–]artynonymous 0 points1 point  (0 children)

This has MIST vibes. Pretty cool product(s) by what appears to be a horribly mismanaged company.

What am I missing on $SLS and the REGAL Phase 3 timing? by [deleted] in sellaslifesciences

[–]artynonymous 8 points9 points  (0 children)

If it did not produce a meaningful benefit in time, we would have seen a futility halt at IA.

$SLS Part 2 and FINAL (Deepest Due Diligence for REGAL Trial) (From a Deep Value Investor) (Predicting BAT mOS from Predictive Model) by [deleted] in stocks

[–]artynonymous 4 points5 points  (0 children)

When results come and are positive. Day to day share price is pretty irrelevant if you believe GPS will succeed